Startups

Will dip in life sciences hurt Philly VC?

Welcome to the VC Roundup, where we’ll parse through venture capital news related to Philadelphia-based private equity firms and the companies they fund. Subscribe to the roundup as an email newsletter. If you have any VC-related news to pass along to us, please drop us a line. Citybizlist has a comprehensive recap of venture activity by a […]


Welcome to the VC Roundup, where we’ll parse through venture capital news related to Philadelphia-based private equity firms and the companies they fund. Subscribe to the roundup as an email newsletter. If you have any VC-related news to pass along to us, please drop us a line.
Citybizlist has a comprehensive recap of venture activity by a handful of firms in the Philadelphia region in 2010. Among the most active? First Round Capital and Edison Ventures.
Philly.com’s Mike Armstrong writes about the 2011’s positive outlook. In case you’ve been keeping track, since 2008 VC’s have thought that the new year would be better than the last. Given the sorry state of 2008 and parts of 2009, can you blame them? Armstong also notes that life science investment appears to have steadied, a potential worry for Philadelphia.
Edison Ventures is among the firms listed in a $12 million investment in Fishbowl, the Virginia-based restuaurant email marketing company.
Philly Tech News reports that Edison Ventures portfolio company GAIN Capital has gone public and the early results aren’t good. The company was trading at $9 a share, below its anticipated $13 to $15 per share.

Companies: GAIN Capital
Engagement

Join the conversation!

Find news, events, jobs and people who share your interests on Technical.ly's open community Slack

Trending

Philly daily roundup: Earth Day glossary; Gen AI's energy cost; Biotech incubator in Horsham

Philly daily roundup: Women's health startup wins pitch; $204M for internet access; 'GamingWalls' for sports venues

Philly daily roundup: East Market coworking; Temple's $2.5M engineering donation; WITS spring summit

From lab to market: Two Philly biotech founders on AI’s potential to revolutionize medicine

Technically Media